Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Domino's Pizza Group PLC
LSE:DOM
|
UK |
|
Karora Resources Inc
TSX:KRR
|
CA |
|
De' Longhi SpA
MIL:DLG
|
IT |
|
Sandfire Resources Ltd
ASX:SFR
|
AU |
|
Suprajit Engineering Ltd
NSE:SUPRAJIT
|
IN |
|
Sphere 3D Corp
F:8S3
|
CA |
|
UBS Group AG
NYSE:UBS
|
CH |
|
C
|
Capgemini SE
XHAM:CGM
|
FR |
|
L
|
LGL Group Inc
AMEX:LGL
|
US |
|
Data Storage Corp
NASDAQ:DTST
|
US |
|
Realty Income Corp
NYSE:O
|
US |
|
N
|
Nesco Ltd
NSE:NESCO
|
IN |
|
Atlas Arteria Group
ASX:ALX
|
AU |
|
C
|
Cintas Corp
SWB:CIT
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Big 5 Sporting Goods Corp
NASDAQ:BGFV
|
US |
|
P
|
Powszechny Zaklad Ubezpieczen SA
WSE:PZU
|
PL |
Bankruptcy Probability
Aspire Biopharma Holdings Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aspire Biopharma Holdings Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PR |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
7.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
573.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
208.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
265.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
334.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aspire Biopharma Holdings Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aspire Biopharma Holdings Inc has total debt of 5.2m USD. This includes both short-term (5.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
